MSB 0.43% $1.15 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-67

  1. 7,527 Posts.
    lightbulb Created with Sketch. 6789
    https://www.bloomberg.com/news/articles/2020-04-22/almost-9-in-10-covid-19-patients-on-ventilators-died-in-study

    "A giant study that examined outcomes for more than 2,600 patients found an extraordinarily high 88% death rate among Covid-19 patients in the New York City area who had to be placed on mechanical devices to help them breathe"

    9/12 patients come off ventilators after 10 days with remestemcel-L. Honestly, listen to any NY medical staff. Basically if you are on ventilator after 5 days, forget it. UK says the same. We've not been exposed here in Australia. Many medical experts were starting to actually question whether ventilators made it worse.

    This is massive. If this does not make national and international headlines, I will be sick, as this evidence suggests MSB might be able to save 100's of thousands of lives. Bugger the share gains. This could potentially end up saving millions.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
-0.005(0.43%)
Mkt cap ! $1.295B
Open High Low Value Volume
$1.15 $1.16 $1.13 $1.478M 1.294M

Buyers (Bids)

No. Vol. Price($)
7 3298 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.15 42944 15
View Market Depth
Last trade - 13.05pm 22/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.